Biocon Biologics Secures PMDA Approval for Ustekinumab Biosimilar

Unknown Apr 02, 2026 2 Views

Biocon Biologics has received approval from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its biosimilar Ustekinumab, designed to compete with Johnson & Johnson's Stelara. This approval enables Biocon to market the biosimilar in Japan, targeting conditions such as psor...

Stay Ahead – Explore Now! Suzhal 2: Kathir, Aishwarya Rajesh Return to Explore Ashtakaali Festival in Gripping Sequel